Education
About Us
Working with TipRanks
Follow Us
LAVA Therapeutics (LVTX)
NASDAQ:LVTX
Lava-1207, Lava-1207 Plus Pembrolizumab
Metastatic Castration Resistant Prostate Cancer
Phase I
Terminated
Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer
Apr 29, 2022
―
Lava-051, Interleukin 2
Multiple Myeloma, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia
Phase I
Terminated
Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML
May 03, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does LAVA Therapeutics (LVTX) have in its pipeline
LVTX is currently developing the following drugs: Lava-1207, Lava-1207 Plus Pembrolizumab, Lava-051, Interleukin 2. These drug candidates are in various stages of clinical development as the company works toward FDA approval.